Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Diabetologist
M.B.B.S, Dip. In Diabetes
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Cardiologist
MBBS, MD(USA), FCPS (Cardiology), DipDiab
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
Gastroenterologist
MBBS, FCPS, ESBGH (UK), SCE Gastro (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Internal Medicine Specialist
M.B.B.S, F.C.P.S, Dip. In (Diabetes) (USA), Dip. In (Gastroenterology) (USA)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures